$ARQT
$28.86
+$1.12 (4.04%)
Overview
$ARQT Overview
Financials
SEC Filings
Executives
News
Specialized Tools
Valuations
P
Insider Transactions
P
Congressional Trades
P
Arcutis Biotherapeutics Inc
arcutis.comArcutis Biotherapeutics (NASDAQ: ARQT) is a biopharmaceutical company focused on developing and commercializing treatments for dermatological conditions. The filing excerpts provided do not contain sufficient detail to describe its revenue model, product portfolio, competitive position, financial results, leadership, or operating geography beyond the company's SEC registration identity. Based solely on the available filing content, no further factual claims about the business can be supported.
Financial Snapshot
Revenue
TTM
$415.6M
Gross Margin
TTM
90.94%
Net Income
TTM
-$2.376M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
268.41%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$189.6M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$16.92M
Loading...
